CG
ANGO icon

Cutler Group’s AngioDynamics ANGO Stock Holding History

Cutler Group’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-422
Closed -$9K – 5624
2021
Q1 		$9K Buy
422
+222
+111% +$4.49K ﹤0.01% 3861
2020
Q4 		$3K Buy
+200
New +$2.54K ﹤0.01% 3890
2017
Q4 		– Sell
-8,275
Closed -$141K – 4825
2017
Q3 		$141K Buy
8,275
+7,539
+1,024% +$127K 0.01% 1405
2017
Q2 		$11K Sell
736
-964
-57% -$15.2K ﹤0.01% 4042
2017
Q1 		$29K Sell
1,700
-600
-26% -$10K ﹤0.01% 2929
2016
Q4 		$38K Buy
+2,300
New +$38.4K ﹤0.01% 2816
2016
Q3 		– Sell
-2,200
Closed -$35.7K – 6597
2016
Q2 		$31K Buy
+2,200
New +$27.5K ﹤0.01% 2855
2016
Q1 		– Sell
-741
Closed -$8K – 6420
2015
Q4 		$8K Buy
+741
New +$9.13K ﹤0.01% 4353

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Cutler Group's ANGO Position: Q2 2021 in Review

Cutler Group sold out of AngioDynamics (ANGO) in Q2 2021, closing a stake of 422 shares — an estimated $9K sold.

Cutler Group first reported a position in ANGO in Q4 2015 and held it in 8 quarters. The position peaked at $141K in Q3 2017. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2021.

  • Cutler Group reported no remaining AngioDynamics position as of Q2 2021 after selling out during the quarter.
  • Cutler Group sold 422 AngioDynamics shares in Q2 2021, an estimated $9K.
  • Cutler Group first reported a position in AngioDynamics in Q4 2015 and held it in 8 quarters.
  • Cutler Group's AngioDynamics position peaked at $141K in Q3 2017.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.